Avai Bio (AVAI) Non-cash Items (2020 - 2023)

Avai Bio has disclosed Non-cash Items across 4 years of filings, most recently posting $2.0 for Q1 2023.

• Non-cash Items for Q1 2023 came in at $2.0, up 100.01% year-over-year; the trailing twelve-month figure through Mar 2023 was $2967.0 (down 74.34% YoY), and the FY2023 annual result was $2967.0, down 74.34% from the prior year.
• Non-cash Items came in at $2.0 for Q1 2023 at Avai Bio, up from -$3487.0 in the prior quarter.
• In the past five years, Non-cash Items ranged from a high of $58830.0 in Q4 2021 to a low of -$30292.0 in Q3 2021.
• The 4-year median for Non-cash Items is -$1197.0 (2020), against an average of $416.25.
• Across the five-year window, Non-cash Items soared 702.21% in 2021 and plunged 272.11% in 2022, its largest moves.
• Avai Bio's Non-cash Items stood at -$9769.0 in 2020, then jumped by 702.21% to $58830.0 in 2021, then slumped by 105.93% to -$3487.0 in 2022, then jumped by 100.06% to $2.0 in 2023.
• The last three Non-cash Items figures came in at $2.0 (Q1 2023), -$3487.0 (Q4 2022), and $1821.0 (Q3 2022), per Business Quant data.